JPWO2007086307A1 - Chemical volatilization device - Google Patents

Abstract

Provided is a chemical volatilization device that can be miniaturized, can be easily installed in a narrow place, and can be easily carried. The chemical volatilization apparatus 10 includes a case 11 having intake ports 20 and 21 and exhaust ports 22 and 22, a cross flow fan 14 disposed in the case 11 and connected to a rotating shaft 15 a of a motor 15, and a cross flow fan. 14 and a medicine holder 17 disposed on the side of the intake ports 20 and 21 of the case 11 in parallel with the longitudinal direction of the case 14.

Description

  The present invention relates to a chemical volatilization device, and more particularly to a chemical volatilization device incorporating a fan.

Conventionally, a chemical volatilization apparatus for volatilizing chemicals for the purpose of insect protection has been used. As a conventional chemical volatilization apparatus, a box is installed on a stand, and a sterilization chamber formed in the box is sterilized. A lamp is provided, and a cross flow fan and a filter built in the box (for example, see Patent Document 1) or a cross flow fan in which a photoactive catalyst is fixed to a blade are used. There are known a fan incorporating a flow fan and an ultraviolet lamp (for example, see Patent Document 2), a fan housing a cross flow fan and a deodorizing element in a main body case (for example, see Patent Document 3), and the like. ing.

Japanese Unexamined Patent Publication No. 8-720 Japanese Patent Laid-Open No. 10-2111268 Japanese Unexamined Patent Publication No. 2005-230043

  However, the chemical volatilization devices described in Patent Documents 1 to 3 are all floor-mounted chemical volatilization devices that are used on the floor, and are large and difficult to install or carry in a small place. Therefore, downsizing of the apparatus is strongly desired.

  The present invention has been made to eliminate such inconveniences, and an object of the present invention is to reduce the size of the apparatus and to easily install it in a narrow place and to carry it easily. An object of the present invention is to provide a chemical volatilization device.

The above object of the present invention can be achieved by the following constitution.
(1) A case having an intake port and an exhaust port, a cross flow fan disposed in the case and connected to the rotating shaft of the motor, and parallel to the longitudinal direction of the cross flow fan and disposed on the intake port side of the case A drug volatilization device comprising: a drug holder.
(2) The chemical volatilization device according to (1), wherein an intake port and an exhaust port are arranged at a position parallel to the longitudinal direction of the cross flow fan.
(3) The case is a portable cylindrical member, in which a cross flow fan is disposed on one side in the longitudinal direction of the case, and a battery for driving a motor is disposed on the other side in the longitudinal direction of the case. The chemical volatilization device according to (1) or (2).
(4) The chemical volatilization device according to any one of (1) to (3), wherein the case has an indicator for confirming the remaining amount of the medicine in the medicine holder.

According to the chemical volatilization device described in (1) above, a case having an intake port and an exhaust port, a cross flow fan disposed in the case and connected to the rotating shaft of the motor, and the longitudinal direction of the cross flow fan Since the cross-flow fan and the medicine holder are arranged in parallel, the apparatus can be miniaturized. Thereby, while being able to install easily in a narrow place, it can carry easily.
According to the chemical volatilization device described in (2) above, since the intake port and the exhaust port are arranged at a position parallel to the longitudinal direction of the cross flow fan, the air blown by the cross flow fan is discharged from the intake port. When it is introduced, it passes through the medicine holder disposed on the intake port side, is blown to the cross flow fan, and releases the medicine to the outside from the exhaust port. As a result, air can be efficiently introduced from the intake port to the crossflow fan, and air can be efficiently blown from the crossflow fan to the exhaust port. Can do.
According to the chemical volatilization device described in (3) above, the case is a portable cylindrical member, the cross flow fan is disposed on one side in the longitudinal direction of the case, and the motor is disposed on the other side in the longitudinal direction of the case. Since the battery for driving the battery is disposed, the device can be miniaturized into a long and thin shape and can be carried like a pen.
According to the medicine volatilization device described in the above (4), the case has an indicator for confirming the remaining amount of the medicine in the medicine holder, so that it is possible to check the replacement time of the medicine holder. For example, by coloring the medicine held in the medicine holder, the color of the medicine holder can be checked from an inspection window that is an indicator at the time of use to check the replacement time of the medicine holder, etc. The remaining amount of the medicine can be confirmed.

According to the chemical volatilization device of the present invention, a case having an intake port and an exhaust port, a cross flow fan disposed in the case and connected to the rotating shaft of the motor, parallel to the longitudinal direction of the cross flow fan, and The device can be downsized, and can be easily installed in a narrow place and can be easily carried around.

It is an appearance perspective view for explaining a 1st embodiment of a chemical volatilization device concerning the present invention. It is a front view of the chemical volatilization apparatus shown in FIG. It is a right view of the chemical volatilization device shown in FIG. It is a front view of the state which removed the cover of the chemical volatilization apparatus shown in FIG. FIG. 3 is a cross-sectional view taken along line AA in FIG. 2. It is a figure which shows 2nd Embodiment of the chemical volatilization apparatus which concerns on this invention, (a) is the front view of the state which removed the cover of the chemical volatilization apparatus, (b) is sectional drawing of a chemical volatilization apparatus. It is a front view of the state which removed the cover of 3rd Embodiment of the chemical volatilization apparatus which concerns on this invention. It is an external appearance perspective view for demonstrating 4th Embodiment of the chemical volatilization apparatus which concerns on this invention.

Explanation of symbols

10, 50, 60, 70 Drug volatilization device 11, 71 Case 12 Case main body 13 Cover 14 Cross flow fan 15 Motor 15a Rotating shaft 15b, 15c Brush terminal 16, 61 Battery 17, 77 Drug holder 18, 62 Switch 20, 21 , 72 Inlet port 22,73 Volatilization port (exhaust port)
23 Fan storage unit 24 Motor fixing unit 25 Battery storage unit 26 Drug holder storage unit 27 Inspection window (indicator)

  Hereinafter, each embodiment of the chemical volatilization device according to the present invention will be described in detail with reference to the drawings.

(First embodiment)
First, with reference to FIGS. 1-5, 1st Embodiment of the chemical volatilization apparatus which concerns on this invention is described.
1 is an external perspective view for explaining a first embodiment of a chemical volatilization apparatus according to the present invention, FIG. 2 is a front view of the chemical volatilization apparatus shown in FIG. 1, and FIG. 3 is a right side of the chemical volatilization apparatus shown in FIG. FIG. 4 is a front view showing a state where the cover of the chemical volatilization apparatus shown in FIG. 1 is removed, and FIG. 5 is a cross-sectional view taken along line AA in FIG.

  As shown in FIGS. 1 to 4, the chemical volatilization device 10 of the present embodiment includes a case 11 having a case body 12 and a cover 13, a cross flow fan 14 disposed in the case 11, a motor 15, and a battery 16. And a medicine holder 17 and a switch 18 disposed on the side surface of the case 11 (the right side surface in FIG. 1).

  The case 11 is a cylindrical member having a substantially egg-shaped cross section, and is formed in an elongated pen shape as a whole. The case 11 is configured to have an integral structure by attaching a cover 13 to the case body 12. Thereby, the battery 16 and the chemical | medical agent holding body 17 can be replaced | exchanged easily only by removing the cover 13 from the case main body 12. FIG. The case 11 has a size that is easy to carry, for example, having a length L of about 90 mm to 130 mm, a width B of about 20 mm to 30 mm, and a thickness D of about 15 mm to 20 mm.

  In addition, the case 11 has air inlets 20 and 21 formed at positions parallel to the cross flow fan 14 on the side surface (right side surface in FIG. 2), and the cross on the front surface (left side surface in FIG. 3). Volatilization ports 22 and 22 that are exhaust ports are formed at positions parallel to the flow fan 14. Among these, the intake port 20 and the volatilization ports 22 and 22 are formed in the cover 13, and the intake port 21 is formed in the case body 12. In addition, the intake ports 20 and 21 and the volatilization ports 22 and 22 are formed in a slit shape so that the width becomes smaller toward the end.

  As shown in FIG. 4, the case main body 12 has a fan housing portion 23 for housing the cross flow fan 14 and a motor fixing portion 24 for fixing the motor 15 from one side in the longitudinal direction to the other side. And a battery storage unit 25 for storing the battery 16 are formed, and the cross flow fan 14, the motor 15, and the battery 16 are arranged in a line. In addition, a medicine holder housing portion 26 for housing the medicine holder 17 is formed in parallel with the fan housing portion 23. Further, the switch 18 is assembled to the side of the motor fixing portion 24 (the right side in FIG. 4).

  A substantially circular inspection window 27 is formed on the upper surface of the case body 12 (upper surface in FIG. 4) as an indicator for confirming the remaining amount of the medicine in the medicine holder 17. The inspection window 27 is for visually observing, for example, the color of the medicine held on the medicine holder 17 and can check the remaining amount of medicine in the medicine holder 17. The indicator may be an LED for checking the remaining amount of the medicine.

  The cross flow fan 14 is incorporated in the fan housing portion 23 of the case body 12, and a rotating shaft 15 a of the motor 15 is connected to an end portion (lower end portion in FIG. 4) of the cross flow fan 14. In the present embodiment, the cross flow fan 14 takes in air from the air inlets 20 and 21 on the side surface of the case 11, changes the direction of the taken air by approximately 90 °, and volatilizes the front side of the case 11. It blows in the direction of 22 and 22.

  The motor 15 is a DC brush motor, and is fixed to the motor fixing portion 24 of the case body 12. Then, when the current is supplied to the pair of brush terminals 15b and 15c, the rotating shaft 15a rotates, and the cross flow fan 14 connected to the rotating shaft 15a is driven. Depending on the type and size of the motor 15, a connecting member that freely curves may be used as a connecting member that connects the cross flow fan 14 and the rotating shaft 15 a of the motor 15. Thereby, the chemical | medical agent volatilization apparatus of the curved form can be obtained.

  The battery 16 is stored in the battery storage section 25 of the case body 12 so as to be aligned on the axis of the crossflow fan 14 and the motor 15. When the switch 18 is turned on, current is supplied to the motor 15. Rotate. In the present embodiment, the battery 16 uses a single AAA-type disposable or rechargeable battery, but a rechargeable battery pack may be used as long as it is a power source capable of obtaining necessary power. Moreover, the size and number of batteries are arbitrary.

  As shown in FIG. 5, the medicine holder 17 is a rod-shaped member having a substantially circular cross section along the intake ports 20 and 21, and is attached to the medicine holder storage portion 26 of the case body 12. The case 11 is disposed on the side of the intake ports 20 and 21 in parallel with the longitudinal direction of the case 11. The medicine holder 17 holds a pre-colored medicine. In addition, the chemical | medical agent holding body 17 should just be a rod-shaped member, and the cross-sectional shape is arbitrary. The medicine holder 17 may be housed in a breathable packaging material or covered with a breathable cover. In this case, the shape of the medicine holder 17 may be any shape that can be stored in a breathable packaging material such as powder, granules, tablets, capsules, and tablets. Furthermore, the medicine holder 17 may be a blade of the cross flow fan 14 or a part of the structure of the cross flow fan 14. In this case, since it is not necessary to arrange the medicine holder 17 on the intake ports 20 and 21 side, the apparatus can be further downsized.

  The material of the medicine holder 17 is not particularly limited as long as the active ingredient can be sufficiently retained. However, the same amount of the active ingredient is continuously applied over a desired time, rather than the one that volatilizes the retained active ingredient at a time. A material that volatilizes voluntarily is preferable. Specifically, papers (filter paper, pulp, linter, cardboard, cardboard, etc.), resins (polyethylene, polypropylene, polyvinyl chloride, highly oil-absorbing polymers, etc.), ceramic, glass fiber, carbon fiber, chemical fiber (polyester) , Nylon, acrylic, vinylon, polyethylene, polypropylene, etc.), natural fiber (cotton, silk, wool, hemp, etc.), non-woven fabric made of glass fiber, carbon fiber, chemical fiber, natural fiber, etc., cotton such as woven fabric, porous Examples thereof include a porous glass material, a porous metal material, and a wire mesh.

Examples of the active ingredient of the medicine to be held in the medicine holder 17 can include pest control agents, bactericides, fragrances, deodorants and the like. Typical examples of pest control components are shown below.
Dl-3-allyl-2-methyl-4-oxo-2-cyclopentenyl dl-cis / trans-chrysanthemate (generic name aresulin: trade name pinamine: manufactured by Sumitomo Chemical Co., Ltd.)
Dl-3-allyl-2-methyl-4-oxo-2-cyclopentenyl d-cis / trans-chrysantemate (trade name: Pinamine Forte: manufactured by Sumitomo Chemical Co., Ltd.)
Dl-3-allyl-2-methyl-4-oxo-2-cyclopentenyl d-trans-chrysanthemate (general name Bioareslin, trade name S-Biol: Yukraf)
D-3-allyl-2-methyl-4-oxo-2-cyclopentenyl d-trans-chrysanthemate (trade name exrin: manufactured by Sumitomo Chemical Co., Ltd.)
・ (5-Benzyl-3-furyl) methyl d-cis / trans-Chrysantemate (generic name Resmethrin: trade name: Chryslon Forte: manufactured by Sumitomo Chemical Co., Ltd.)
5-Propagyl-2-furylmethyl-d-cis / trans-Chrysantemate (generic name furamethrin: trade name pinamine D forte: manufactured by Sumitomo Chemical Co., Ltd.)
(+)-2-methyl-4-oxo-3- (2-propynyl) -2-cyclopentenyl (+)-cis / trans-chrysantemate (generic name: plaretrin, trade name Etok: Sumitomo Chemical Co., Ltd.) Made)
Dl-3-allyl-2-methyl-4-oxo-2-cyclopentenyl-dl-cis / trans-2,2,3,3-tetramethylcyclopropanecarboxylate (generic name: Terrareslin: Sumitomo Chemical Co., Ltd.) Company-made)
(1,3,4,5,6,7-hexahydro-1,3-dioxo-2-isoindolyl) methyl-dl-cis / trans-chrysantemate (generic name phthalusrin, trade name Neopinamine: Sumitomo Chemical Co., Ltd.) Company-made)
(1,3,4,5,6,7-hexahydro-1,3-dioxo-2-isoindolyl) methyl-d-cis / trans-chrysantemate (trade name Neopinamine Forte: Sumitomo Chemical Co., Ltd.) Made)
3-phenoxybenzyl-d-cis / trans-chrisantemate (generic name phenothrin, trade name Smithin: manufactured by Sumitomo Chemical Co., Ltd.)
3-phenoxybenzyl-dl-cis / trans-3- (2,2-dichlorovinyl) -2,2-dimethyl-1-cyclopropanecarboxylate (generic name permethrin, trade name Exmin: manufactured by Sumitomo Chemical Co., Ltd.) )
(±) α-cyano-3-phenoxybenzyl (+)-cis / trans-Chrysanthemate (generic name ciphenothrin, trade name Gokyrat: manufactured by Sumitomo Chemical Co., Ltd.)
1-ethynyl-2-methyl-2-pentenyl dl-cis / trans-3- (2,2-dimethylvinyl) -2,2-dimethyl-1-cyclopropanecarboxylate (generic name empentrin, trade name vaporsulin) : Sumitomo Chemical Co., Ltd.)
D-trans-2,3,5,6-tetrafluorobenzyl-3- (2,2-dichlorovinyl) -2,2-dimethyl-1-cyclopropanecarboxylate (generic name transfluthrin)
1-ethynyl-2-methyl-2-pentenyl 3- (2,2-dichloroethenyl) -2,2-dimethylcyclopropanecarboxylate and the like.

  Further, for example, compounds that are structurally similar to the above-described compounds and have substantially the same medicinal properties can also be mentioned. For example, in the case of Empentrin, the two substituents at the 3-position are methyl groups, but compounds having other alkyl groups, unsaturated alkyl groups or halogen atoms as the substituents can also be used. In addition, fiproneil, imiprothrin, furanyl insecticide dinotefuran (chemical name: (RS) -1-methyl-2-nitro-3- (tetrahydro-3-furylmethyl) guanidine), trichlorfone, cartap, Acetamiprid, Imidacloprid (Imidacloprid, manufactured by Bayer Agrochem, Japan), Nitenpyram (Nitenpyram, manufactured by Sumika Takeda Agricultural Chemicals), Thiacloprid (Thiacloprid, manufactured by Bayer Agrochem, Japan), Clotianidin (manufactured by Clotianidin, Sumika Takeda) Thiamethoxam (Thiamethoxam, manufactured by Syngenta), propoxur (Propoxur, manufactured by Bayer Yakuhin), pymetrozine (Pymetrozine, manufactured by Syngenta), fenitrothio (Sumitomo Chemical), Fention (Bayer), Metofluthrin (Sumitomo Chemical), Profluthrin (Sumitomo Chemical), Amidoflumet (Sumitomo Chemical), Insecticide extract, plant essential oil, etc. Isopropyl (2E-2E) -11-methoxy-3,7,11-trimethyl-2,4-trimethyldodeca-2,4-dienoate), pyriproxyfen, 82- [1-methyl-2- (phenoxyphenoxy) Insect juvenile hormone such as ethoxy] pyridine), diflupendurone (1- (4-chlorophenyl) -3- (2,6-difluorobenzoyl) urea), teflubenzuron (1- (3,5-difluorobenzoyl) urea), etc. Insect chitin formation inhibiting compounds and the like.

Among these, those that are volatile at room temperature (vapor pressure: 1.0 × 10 ^{−2 to} 1.0 × 10 ⁻⁶ mmHg) are preferable, and praretrin, resmethrin, bioaresulin, framethrin, terrareslin, transfluthrin, Metofluthrin and profluthrin are particularly preferred. Such pest control components may be used alone or in combination. These analogs are also used. Of these, those that are likely to volatilize at room temperature include, for example, a cover for adjusting volatilization, hydrocarbons such as polybutene, isoparaffin, normal paraffin, hexyl laurate, isopropyl myristate, butyl phthalate, etc. By using together with a volatilization regulator composed of these esters, it becomes difficult to volatilize and a pest control effect can be obtained over a long period of time.

  As an additive to reduce the viscosity of liquid drugs for easy retention of drugs, fatty acid esters such as isopropyl myristate, isopropyl palmitate and hexyl laurate, and solvents such as isopropyl alcohol, polyethylene glycol, and deodorized kerosene are required. Can be used according to. Moreover, when hold | maintaining a chemical | medical agent, this can be hold | maintained with another auxiliary component, for example, if a sublimation substance is added as an auxiliary for transpiration | evaporation, a volatilization effect may be improved. When a pyrethroid compound is used as a pest control component, it is also preferable to mix known synergists effective against this. Furthermore, when an antioxidant such as BHT or BHA or an ultraviolet absorber is added, stability against light, heat, oxidation, etc. is enhanced.

  In addition, the medicine holder 17 holds the active ingredient or the like in the medicine holder 17 by applying a liquid application method such as drop coating, impregnation coating, spray coating, etc., liquid printing, brush coating, etc. Or a method of attaching to the medicine holder 17 can be used. Further, when the composition of the drug to be used is not liquid or when no solvent is used, methods such as kneading, coating, and printing can be applied.

  The amount of the active ingredient held in the drug holding body 17 is usually up to the saturated impregnation amount of the drug holding body 17, but by connecting a separate replenishing container to the drug holding body 17 via a liquid absorbing material, It can also be made into a usable form until there is no liquid in the container continuously over a long period of time.

  The switch 18 is a slide-type switch, and includes a movable plate 31 on which the operation unit 30 is formed, a contact plate 32 that is a movable contact fixed to the back surface of the movable plate 31, and the contact plate 32 electrically. First and second contactors 33 and 34 to be separated from each other and three conductive metal first, second and third bus bars 35, 36 and 37 are provided. In the present embodiment, a slide-type switch is used as the switch 18, but instead of this, a snap-type switch or a button-type switch may be used.

  The movable plate 31 is slidably assembled in a guide groove 38 formed in the case main body 12, and slides together with the contact plate 32 as the operation unit 30 is pressed.

  The first contactor 33 is electrically connected to one end of the first bus bar 35, and the other end of the first bus bar 35 is electrically connected to one brush terminal 15 b of the motor 15.

  The second contactor 34 is electrically connected to one end portion of the second bus bar 36, and the other end portion of the second bus bar 36 is electrically connected to the negative side of the battery 16 in the battery housing portion 25. Yes.

  One end portion of the third bus bar 37 is electrically connected to the other brush terminal 15 c of the motor 15, and the other end portion is electrically connected to the positive side of the battery 16 in the battery housing portion 25.

  In the chemical volatilization apparatus 10 configured as described above, as shown in FIG. 1, by sliding the operation unit 30 to the ON position, the electricity of the battery 16 is changed to the plus side of the battery 16 → the third bus bar 37 → the motor 15. The brush terminal 15c → the brush terminal 15b of the motor 15 → the first bus bar 35 → the first contactor 33 → the contact plate 32 → the second contactor 34 → the second bus bar 36 → the negative side of the battery 16 flows in this order. As a result, the rotating shaft 15a of the motor 15 rotates and drives the cross flow fan 14. Then, when the cross flow fan 14 is driven, external air is introduced into the cross flow fan 14 via the intake ports 20 and 21 and the medicine holder 17 as shown by arrows in FIG. The air blown by the fan 14 releases the drug volatilized from the drug holding body 17 through the volatilization ports 22 and 22 to the outside.

  Further, by sliding the operation unit 30 from the ON position to the OFF position in the front direction in FIG. 1, the contact plate 32 slides together with the movable plate 31, and the first contactor 33 moves away from the contact plate 32. The circuit is interrupted and the motor 15 stops.

  Therefore, according to the chemical volatilization apparatus 10 of the present embodiment, the case 11 having the intake ports 20 and 21 and the volatilization ports 22 and 22, the cloth disposed in the case 11 and connected to the rotating shaft 15 a of the motor 15. Since the cross-flow fan 14 and the drug holding body 17 are provided with the flow fan 14 and the drug holding body 17 arranged in parallel to the longitudinal direction of the cross-flow fan 14 and on the intake ports 20 and 21 side of the case 11. Since the devices are arranged in parallel, the device 10 can be reduced in size. Thereby, while being able to install easily in a narrow place, it can carry easily.

  Moreover, according to the chemical volatilization apparatus 10 of this embodiment, since the inlet ports 20 and 21 and the volatilization ports 22 and 22 are arranged at positions parallel to the longitudinal direction of the cross flow fan 14, the cross flow fan 14 blows air. When the air is introduced from the intake ports 20 and 21, the air passes through the drug holder 17 disposed on the intake ports 20 and 21 side, is blown to the cross flow fan 14, and the drug is discharged from the volatilization ports 22 and 22. Release to the outside. Accordingly, air can be efficiently introduced from the intake ports 20 and 21 to the cross flow fan 14 and air can be efficiently blown from the cross flow fan 14 to the volatilization ports 22 and 22. It is possible to efficiently volatilize 17 drugs.

  Moreover, according to the chemical volatilization device 10 of the present embodiment, the case 11 is a portable cylindrical member, the cross flow fan 14 is disposed on one side in the longitudinal direction of the case 11, and the longitudinal direction of the case 11 is Since the battery 16 for driving the motor 15 is disposed on the other side, the device 10 can be reduced in size to a long and thin shape and can be carried like a pen.

  Moreover, according to the chemical volatilization apparatus 10 of the present embodiment, the case 11 has the inspection window 27 as an indicator for confirming the remaining amount of the medicine in the medicine holder 17, so that the replacement time of the medicine holder 17 can be set. Can be confirmed. For example, by coloring the medicine held on the medicine holder 17, the color of the medicine holder 17 is checked from the inspection window 27 that is an indicator at the time of use, and the replacement time of the medicine holder 17 is confirmed. can do.

  Furthermore, according to the drug volatilization apparatus 10 of this embodiment, since the drug volatilization apparatus 10 is a size that is easy to carry, the apparatus 10 can be carried in a pocket such as a jacket or pants. Further, for example, a string can be tied to the case 11, and the string can be wrapped around the neck, suspended in front of the chest, or wrapped around the wrist or arm. Furthermore, for a small space such as a room, it can be attached around a desk or a sink, hung, or installed around a window frame or door frame.

(Second Embodiment)
Next, with reference to FIG. 6, the chemical volatilization apparatus 50 which is 2nd Embodiment of this invention is demonstrated. In addition, about the part which overlaps with 1st Embodiment, the same code | symbol is attached | subjected to a figure, and the description is abbreviate | omitted or simplified.
FIG. 6 is a view showing a second embodiment of the drug volatilization apparatus according to the present invention, wherein (a) is a front view of a state where the cover of the drug volatilization apparatus is removed, and (b) is a sectional view of the drug volatilization apparatus. .

  As shown in FIG. 6, the chemical volatilization apparatus 50 according to the present embodiment is provided with the battery storage unit 25 on the side of the motor fixing unit 24 (the right side of FIG. 6), and the motor 15 and the battery 16 are arranged in parallel. ing. Further, the switch 18 is disposed on the side surface portion (left side surface portion in FIG. 6) of the case 11 on the motor 15 side.

According to the chemical volatilization apparatus 50 of this embodiment, since the cross flow fan 14 and the chemical | medical agent holding body 17 are arrange | positioned in parallel and the motor 15 and the battery 16 are arranged in parallel, from the chemical volatilization apparatus 10 of 1st Embodiment. Can also shorten the length. Thereby, the portability of the apparatus can be improved.
About another structure and an effect, it is the same as that of 1st Embodiment mentioned above.

(Third embodiment)
Next, with reference to FIG. 7, the chemical volatilization apparatus 60 which is 3rd Embodiment of this invention is demonstrated. In addition, about the part which overlaps with 1st Embodiment, the same code | symbol is attached | subjected to a figure, and the description is abbreviate | omitted or simplified.
FIG. 7: is a front view of the state which removed the cover of 3rd Embodiment of the chemical volatilization apparatus based on this invention.

  As shown in FIG. 7, the chemical volatilization apparatus 60 according to the present embodiment is provided with a battery storage unit 25 on the side of the motor fixing unit 24 (on the right side in FIG. 7). , 61 are stored alternately. In addition, a switch 62 is disposed on the side of the battery storage unit 25 (on the right side in FIG. 7). Thereby, the motor 15, the batteries 61 and 61, and the switch 62 are arranged in parallel.

  The switch 62 fixes the first contactor 63 to the movable plate 31, and the first contactor 63 is always electrically connected to the second contactor 64. Further, the first bus bar 66 for conduction is electrically connected to one side of the batteries 61, 61 (left side in FIG. 7), and the first contactor 63 is detachably arranged on the plus side of the one battery 61. The third contactor 65 is electrically connected to the negative side of the other battery 61. Further, the second contactor 64 is electrically connected to the brush terminal 15 c of the motor 15 via the second bus bar 67, and the third contactor 65 is electrically connected to the brush terminal 15 b of the motor 15 via the third bus bar 68. Connected to.

  In the chemical volatilization apparatus 60 configured as described above, as shown in FIG. 7, by sliding the operation unit 30 to the ON position, the electricity of the batteries 61 and 61 is changed from the plus side of the one battery 61 to the first contactor. It flows in the order of 63 → second contactor 64 → second bus bar 67 → brush terminal 15c of motor 15 → brush terminal 15b of motor 15 → third bus bar 68 → third contactor 65 → minus side of the other battery 61. As a result, the rotating shaft 15a of the motor 15 rotates and drives the cross flow fan 14. Further, the first contactor 63 is slid together with the movable plate 31 by sliding the operation unit 30 from the on position to the off position in the front direction in FIG. 7, and the first contactor 63 is moved to the plus side of one battery 61. Therefore, the energization circuit is cut off and the motor 15 is stopped.

Therefore, according to the medicine volatilization apparatus 60 of the present embodiment, the cross flow fan 14 and the medicine holder 17 are arranged in parallel, and the motor 15, the batteries 61 and 61, and the switch 62 are arranged in parallel, and the batteries 61 and 61 are arranged. Since the button-type battery is used, the length can be further shortened compared to the drug volatilization apparatuses 10 and 50 of the first and second embodiments. Thereby, the portability of the apparatus can be further improved.
About another structure and an effect, it is the same as that of 1st Embodiment mentioned above.

(Fourth embodiment)
Next, with reference to FIG. 8, the chemical volatilization apparatus 70 which is 4th Embodiment of this invention is demonstrated. In addition, about the part which overlaps with 1st Embodiment, the same code | symbol is attached | subjected to a figure, and the description is abbreviate | omitted or simplified.
FIG. 8 is an external perspective view for explaining a fourth embodiment of the chemical volatilization apparatus according to the present invention.

  As shown in FIG. 8, the chemical volatilization apparatus 70 of the present embodiment includes a case 71 having a first case portion 75 and a second case portion 76, a cross flow fan 14 disposed in the first case portion 75, and The motor 15, the battery 16 disposed in the second case portion 76, and a medicine holder 77 attached to the second case portion 76 are provided.

  The case 71 is a cylindrical member having a substantially circular cross section, and is formed in an elongated pen shape as a whole. The case 71 is configured to be integrated with the first case portion 75 by assembling the second case portion 76. . Thereby, the battery 16 and the chemical | medical agent holding body 77 can be replaced | exchanged at once only by removing the 2nd case part 76 from the 1st case part 75. FIG.

  The cross flow fan 14 and the motor 15 are arranged in the longitudinal direction inside the first case portion 75, and a plurality of air inlets 72, 72 and one volatilization are provided on the side surface portion of the first case portion 75. A mouth 73 is formed.

  A drug holding frame 78 for attaching the drug holding body 77 is formed on one side in the longitudinal direction of the second case portion 76, and the battery 16 is built in the other side in the longitudinal direction of the second case portion 76. . In addition, a switch (not shown) is assembled to the other side surface portion of the second case portion 76.

  The medicine holder 77 is a planar member along the air inlets 72, 72, and is attached to the medicine holding frame 78 of the second case 76, parallel to the longitudinal direction of the cross flow fan 14, and the air intake of the case 71. It arrange | positions at the mouths 72 and 72 side. In addition, as the medicine to be held by the medicine holder 77, the same one as in the first embodiment described above is used.

  In the chemical volatilization device 70 configured in this way, the second case portion 76 is assembled to the first case portion 75 to form an integrally structured case 71, and the case 71 is crossed from one side in the longitudinal direction toward the other side. The flow fan 14, the motor 15, and the battery 16 are arranged in a line. Further, at the time of assembly, the motor 15 in the first case portion 75 and the battery 16 in the second case portion 76 are electrically connected, and the motor 15 is turned on by turning on a switch (not shown). The rotation shaft 15a rotates, and the cross flow fan 14 is driven.

Therefore, according to the medicine volatilization apparatus 70 of the present embodiment, the first case part 75 containing the cross flow fan 14 and the motor 15, and the second case part 76 containing the battery 16 and to which the medicine holder 77 is attached. , And the second case portion 76 is assembled to the first case portion 75 to form a case 71 having an integral structure. Therefore, the device 10 can be further reduced in size, and the first case portion 75 can be reduced to the second case. The battery 16 and the medicine holder 77 can be replaced at a time simply by removing the case portion 76. Note that the battery 16 may be a button battery, and the second case portion 76 may be sized appropriately.
About another structure and an effect, it is the same as that of 1st Embodiment mentioned above.

  Below, the volatilization test performed in order to confirm the effect of the volatilization chemical | medical agent container (this Example) of this invention is demonstrated.

  The present example used for this test is the volatile drug container 70 of the fourth embodiment, and the reference example is the intake 72, the drug holder 77 of the volatile drug container 70 of the fourth embodiment. It is arranged not on the 72 side but on the volatilization port (exhaust port) 73 side. Further, the drug holding body 77 is obtained by impregnating 20 mg of metfurthrin in a Toray polyester mesh (T1107 / 888, size 15 × 40 mm, one layer). Furthermore, the voltage applied to the motor 15 was 1.5V.

  In this test, one example and one reference example were prepared, and each was driven to measure the air volume and the chemical volatilization amount. The results are shown in Table 1.

  As is clear from Table 1, the reference example has an air volume of 0.61 liter / sec and a chemical volatilization amount of 0.03 mg / hr, whereas this example has an air volume of 0.43 liter / sec. Since the chemical volatilization amount was 0.06 mg / hr, it was found that even in the case where the same voltage was applied to the motor, the loss of the airflow was greater in this example, but the chemical volatilization amount was large. Thereby, it has confirmed that the inlet side was desirable for the installation place of the chemical | medical agent holding body in the chemical volatilization apparatus of this invention.

Although the present invention has been described in detail and with reference to specific embodiments, it will be apparent to those skilled in the art that various changes and modifications can be made without departing from the spirit and scope of the invention.
This application is based on a Japanese patent application (Japanese Patent Application No. 2006-017914) filed on Jan. 26, 2006, the contents of which are incorporated herein by reference.

Claims (4)

A case having an intake port and an exhaust port;
A cross flow fan disposed in the case and connected to the rotating shaft of the motor;
A drug volatilization device comprising: a drug holder parallel to a longitudinal direction of the cross flow fan and disposed on the suction port side of the case.   The chemical volatilization device according to claim 1, wherein the intake port and the exhaust port are arranged at a position parallel to the longitudinal direction of the cross flow fan.   The case is a portable cylindrical member, the cross flow fan is arranged on one side in the longitudinal direction of the case, and a battery for driving the motor is arranged on the other side in the longitudinal direction of the case. The chemical volatilization device according to claim 1 or 2.   The said case has an indicator for confirming the residual amount of the chemical | medical agent of the said chemical | medical agent holding body, The chemical volatilization apparatus in any one of Claims 1-3 characterized by the above-mentioned.

Images